GLYCOS BIOTECHNOLOGIES

glycos-biotechnologies-logo

Glycos Biotechnologies, Inc. enables the fuels and chemicals industries of the future. Their partners can flexibly make high value products from a wide range of non-food feedstocks, increasing profits and reducing carbon footprint. They partner with ethanol companies, biodiesel companies and chemical companies interested in leveraging existing infrastructure into alternative chemicals and fuels production. They are also collaborating with biorefinery manufacturers and plant operators to deliver the technology for an integrated biorefinery solution.

#SimilarOrganizations #People #Financial #Website #More

GLYCOS BIOTECHNOLOGIES

Industry:
Biotechnology Chemical Renewable Energy

Founded:
2007-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.glycosbio.com

Total Employee:
11+

Status:
Active

Contact:
713-869-9377

Email Addresses:
[email protected]

Total Funding:
19.39 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Google Apps For Business AJAX Libraries API Google Google Cloud


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

genomatica-logo

Genomatica

Genomatica manufactures sustainable chemicals from renewable feedstocks.

newlight-technologies-logo

Newlight Technologies

Newlight Technologies is a biotechnology company producing advanced sustainable materials.

codex-dna-logo

Codex DNA

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA.

zymochem-logo

Zymochem

Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.


Current Advisors List

steve-jurvetson_image

Steve Jurvetson Member of Board of Directors @ Glycos Biotechnologies
Board_member

not_available_image

Walter S. Burnap Board Member @ Glycos Biotechnologies
Board_member

not_available_image

Gary Mossman Board Of Directors @ Glycos Biotechnologies
Board_member

dan-watkins_image

Dan Watkins Boards of Directors @ Glycos Biotechnologies
Board_member

Current Employees Featured

daniel-jmonticello_image

Daniel J.Monticello
Daniel J.Monticello Vice President, Research and Development @ Glycos Biotechnologies
Vice President, Research and Development

richard-c-cilento-jr_image

Richard C. Cilento, Jr.
Richard C. Cilento, Jr. CEO @ Glycos Biotechnologies
CEO
2016-01-01

not_available_image

Walter S. Burnap
Walter S. Burnap President and Chief Financial Officer @ Glycos Biotechnologies
President and Chief Financial Officer

werner-bussmann_image

Werner Bussmann
Werner Bussmann Vice President, Program Management @ Glycos Biotechnologies
Vice President, Program Management

kevin-dmitchell_image

Kevin D.Mitchell
Kevin D.Mitchell Vice President, Finance @ Glycos Biotechnologies
Vice President, Finance

Founder


ramon-gonzalez_image

Ramon Gonzalez

Investors List

texas-halo-fund_image

Texas HALO Fund

Texas HALO Fund investment in Seed Round - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Debt Financing - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Debt Financing - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Debt Financing - Glycos Biotechnologies

eiv-capital_image

EIV Capital

EIV Capital investment in Series B - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Series B - Glycos Biotechnologies

dnx-ventures_image

DNX Ventures

DNX Ventures investment in Series B - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Series B - Glycos Biotechnologies

gideon-hixon-fund_image

Gideon Hixon Fund

Gideon Hixon Fund investment in Series B - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Series A - Glycos Biotechnologies

Official Site Inspections

http://www.glycosbio.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Glycos Biotechnologies"

Home | GlycosBio, Inc.

GlycosBio is focused on research and development to improve the therapeutic performance of natural bioactive molecules to the body using engineered lipid technologies. The concept of โ€ฆSee details»

Glycos Biotechnologies - Crunchbase Company Profile

Organization. Glycos Biotechnologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โ€ฆSee details»

GlycosBio, Inc. - LinkedIn

GlycosBio, Inc. Biotechnology Research Houston, Texas 1,016 followers Clinically Driven - Personalized Care for a Healthy MicrobiomeSee details»

GlycosBio Company Profile 2024: Valuation, Funding

GlycosBio General Information Description. Developer of nutritional products designed to support specific medical needs. The company's nutritional products are more easily absorbed and โ€ฆSee details»

Contact Us | GlycosBio, Inc.

Unlocking the Therapeutic Value of Natural Materials. GlycosBio. Copyright © 2023 GlycosBio, Inc.See details»

Glycos Biotechnologies - Overview, News & Similar โ€ฆ

Glycos Biotechnologies, Inc. (GlycosBio) is an international biochemical company focused on the commercialization of advanced metabolic engineering and microbial strain development which โ€ฆSee details»

GlycosBio - Company Profile - Tracxn

Nov 7, 2024 GlycosBio is a scientifically focused biotechnology company with expertise in molecular biology as well as metabolic engineering. The company leverages metabolic โ€ฆSee details»

Lipid Engineering - GlycosBio, Inc.

GlycosBioโ€™s lipid engineering technologies harness the innate bioactive qualities in natural lipid structures to help Clients modernize OTC consumer and personal care products. Our Mission โ€ฆSee details»

GlycosBio - Products, Competitors, Financials, Employees, โ€ฆ

Aug 20, 2011 GlycosBio has a specific interest in synthetic rubber intermediates including bio-derivedisoprene. Solixโ€™s crude algal oil was found to be non-toxic and easily metabolized and โ€ฆSee details»

GlycosBio Food Sciences - VentureRadar

GlycosBio is a food science company that develops and produces advanced nutritional products. We apply the principles of human nutrition and biotechnology to produce scientifically tested, โ€ฆSee details»

Glycos Biotechnologies - Craft

GlycosBio is a food science company that develops and produces advanced nutritional products. Its products address specific dietary deficiencies in individuals with varying health conditions. โ€ฆSee details»

Richard Cilento - FibroBiologics

Richard C. Cilento, Jr. Board of Directors Mr. Cilento has served on our board of directors since April 2021. Mr. Cilento is the founder, Chairperson of the board of directors and Chief โ€ฆSee details»

BiotechCorp Grants BioNexus Status to GlycosBio - Crop โ€ฆ

Feb 25, 2011 GlycosBio is presently constructing an industrial biochemical plant and biotechnology research and development facility in Bio-XCell, a dedicated biotechnology park โ€ฆSee details»

Glycos Biotechnologies - EquityNet

Glycos Biotechnologies, Inc. enables the fuels and chemicals industries of the future. Their partners can flexibly make high value products from a wide range of non-food feedstocks, โ€ฆSee details»

Enhanced Delivery Research | GlycosBio, Inc.

GlycosBio has developed a library of lipids designed to significantly enhance the permeability of molecules through the skin to improve the performance of target molecules. With the advice of โ€ฆSee details»

Glycos Biotech Raises $5 Million - venturecapitaljournal.com

Apr 19, 2009 Glycos Biotechnologies, Inc. (GlycosBio) announced the closing of a $5.0 million Series A round of financing led by venture capital firms Draper Fisher Jurvetson (DFJ) and โ€ฆSee details»

Glycos Biotechnologies, Inc. Closes Series A Round of $5 โ€ฆ

Apr 17, 2009 Glycos Biotechnologies, Inc. (GlycosBio) announced the closing of a $5.0 million Series A round of financing led by venture capital firms Draper Fishe.See details»

GlycosBio Careers and Employment | Indeed.com

Jun 10, 2015 Find out what works well at GlycosBio from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular โ€ฆSee details»

Bioavailability Research | GlycosBio, Inc.

Clinical Study: PERT-Free Nutrition, Cystic Fibrosis We designed and clinically tested the first medical food specifically designed for cystic fibrosis patients that bypasses the need for โ€ฆSee details»

Microbiota Research | GlycosBio, Inc.

GlycosBio's scientific team is dedicated to the development of elemental natural products that address microbiota dysbiosis. The concept of selectively influencing the intestinal, pulmonary, โ€ฆSee details»

linkstock.net © 2022. All rights reserved